Taipei Exchange - Delayed Quote TWD

TWi Biotechnology, Inc. (6610.TWO)

Compare
13.75
+0.10
+(0.73%)
At close: 1:29:36 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Ms. Yijun Wu Chairman of the Board & President -- -- --
Dr. Chih-Ming Chen Ph.D. Founder -- -- --
Mr. Guang-Wei Lu Ph.D. Senior Vice President of R&D -- -- --
Dr. Chen-En Tsai M.D., Ph.D. GM & Chief Medical Officer -- -- --

TWi Biotechnology, Inc.

No. 41, Lane 221
8th Floor Kang Chien Road Neihu District
Taipei, 11494
Taiwan
886 2 2657 1788 https://www.twibiotech.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
21

Description

TWi Biotechnology, Inc., a clinical-stage biopharmaceutical company, develops and sells drugs for innate immunity-related diseases in Taiwan. The company development pipeline comprises AC-203, which is in Phase 2 clinical trial for various indications, including epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus; and AC- 1101, which is in Phase 1 trial for the treatment of vitiligo and preclinical stage for the treatment of atopic dermatitis, as well as granuloma annulare and rare autoimmune skin diseases. It has a drug development agreement with Hong Kong Winhealth Pharma Group Co., Limited. in Mainland China, Hong Kong, and Macao markets. TWi Biotechnology, Inc. was founded in 2010 and is based in Taipei, Taiwan.

Corporate Governance

TWi Biotechnology, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
7.98
-2.80%
 
6580.TWO TaiRx, Inc.
26.00
+1.96%
 
4197.TWO Visgeneer Inc.
9.78
0.00%
 
6709.TWO Advagene Biopharma Co., Ltd.
20.25
+0.25%
 
4195.TWO Genomics BioSci & Tech. Co.,Ltd.
18.90
+2.16%
 
6652.TWO Eusol Biotech Co.,Ltd.
7.77
-0.38%
 
6634.TWO Sinew Pharma Inc.
49.45
-0.40%
 
4178.TWO StemCyte International, Ltd.
35.15
+1.59%
 
4194.TWO Holy Stone Healthcare Co., Ltd.
11.40
-0.44%
 
4170.TWO VBI
14.10
+0.71%